A.I. Virtanen Institute for Molecular Sciences - News

Funding was granted from the Horizon Europe Programme to the NEMESIS project investigating the role of environmental chemicals as disrupters of normal human metabolism.

The University of Eastern Finland coordinates two funded Flagships, GeneCellNano and UNITE, and is a partner in the ACCC Flagship.

Erkko Ylösmäki is the new CEO of Rokote Laboratories Finland, a research-based company developing a coronavirus vaccine. Clinical trials will start by the end of summer 2024 at the earliest.

The PhD thesis assesses the potential and limitations of advanced non-invasive MRI such as diffusion tensor imaging (DTI) to investigate microstructural changes in brain damage pathology.

The doctoral study investigates the role of the trigeminal transmembrane mechanosensitive Piezo1 channels in triggering pain and explores how the endocannabinoid system can potentially bring relief.

The concepts of an AI-powered memory support application and a wearable biomarker and EEG device for at-home sleep monitoring took home the prizes from The Olvi Foundation Neurochallenge innovation competition.

Exposure to ultrafine particles from traffic alters the expression of many genes in human olfactory mucosa cells, a new study shows.

A new study by researchers and clinicians at UEF and Helsinki University Hospital provides novel insight into the previously unknown effects of fibroblasts in regulating blood vessel formation in vascular malformations.

The Outstanding Achievement Award is the most prestigious award conferred by the European Society of Gene and Cell Therapy, ESGCT.

Examining cortical biopsy samples from living individuals, researchers discovered early Alzheimer’s disease-associated cellular changes in three cell types.